Related references
Note: Only part of the references are listed.The significant role of mast cells in cancer
Khashayarsha Khazaie et al.
CANCER AND METASTASIS REVIEWS (2011)
Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers
Paola Pittoni et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Tumor Promotion via Injury- and Death-Induced Inflammation
Ali Kuraishy et al.
IMMUNITY (2011)
被撤回的出版物: FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer (Retracted article. See vol. 125, pg. 2179, 2015)
Stephanie K. Watkins et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
Mast cell mediators in tolerance
Victor C. de Vries et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Direct Activation of Forkhead Box 03 by Tumor Suppressors p53 and p73 Is Disrupted During Liver Regeneration in Mice
Svitlana Kurinna et al.
HEPATOLOGY (2010)
被撤回的出版物: Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells (Retracted article. See vol. 76, pg. 2490, 2016)
Kimberly A. Shafer-Weaver et al.
CANCER RESEARCH (2009)
Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells
Kimberly A. Shafer-Weaver et al.
JOURNAL OF IMMUNOLOGY (2009)
Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells
Anne S. Dejean et al.
NATURE IMMUNOLOGY (2009)
Mast Cells Multifaceted Immune Cells with Diverse Roles in Health and Disease
Kavitha N. Rao et al.
YEAR IN IMMUNOLOGY 2008 (2008)
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz et al.
IMMUNOLOGICAL REVIEWS (2008)
Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4+ regulatory T cells
N. Cools et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Cutting edge:: Autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity
Stephen J. Galli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Balancing between immunity and tolerance: An interplay between dendritic cells, regulatory T cells, and effector T cells
Nathalie Cools et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer
Michael J. Anderson et al.
JOURNAL OF IMMUNOLOGY (2007)
Dendritic cells and tumor microenvironment: A dangerous liaison
Ingo Fricke et al.
IMMUNOLOGICAL INVESTIGATIONS (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
Regulation of NF-κB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a
L Lin et al.
IMMUNITY (2004)
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice
F Fallarino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Share Paper
